Valuation: AstraZeneca PLC

Market Cap 262B 230B 214B 197B 369B 25,288B 376B 2,551B 996B 12,349B 983B 962B 42,908B P/E 2026 *
21.1x
P/E 2027 * 18.5x
Enterprise Value 281B 247B 230B 211B 396B 27,142B 403B 2,737B 1,069B 13,254B 1,055B 1,032B 46,053B EV / Sales 2026 *
4.45x
EV / Sales 2027 * 4.1x
Free-Float
96.63%
Yield 2026 *
1.98%
Yield 2027 * 2.09%

Last Transcript: AstraZeneca PLC

1 day-0.11%
1 week+0.97%
Current month-10.01%
1 month-4.53%
3 months-12.71%
6 months-6.43%
Current year-7.99%
1 week 10,524
Extreme 10524
12,778
1 month 10,524
Extreme 10524
14,686
Current year 10,524
Extreme 10524
15,732
1 year 10,524
Extreme 10524
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
7/6/26 Free

See Remarks

2 0.0000%
6/8/26 Free

See Remarks

1 0.0000%
5/20/26 Sell

See Remarks

-11,893 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.11%+0.97%+22.57%+17.81% 264B
+1.97%+2.53%+52.73%+156.66% 1,037B
+1.42%+4.96%+54.39%+52.34% 615B
+1.43%+5.25%+37.31%+78.74% 448B
+5.14%+5.84%+37.54%+27.28% 326B
+1.85%+4.64%+38.53%+39.87% 293B
+0.25%-3.10%-24.44%-42.25% 216B
+1.49%+3.68%+21.53%+58.21% 198B
+0.40%-0.64%+18.78%+62.28% 162B
+0.77%+0.77%-0.52%-33.13% 141B
Average +0.70%+1.01%+25.84%+41.78% 369.89B
Weighted average by Cap. +0.42%+1.42%+36.84%+71.09%

Financials

2026 *2027 *
Net sales 63.21B 55.55B 51.62B 47.48B 89.01B 6,103B 90.72B 616B 240B 2,980B 237B 232B 10,356B 66.78B 58.69B 54.54B 50.16B 94.04B 6,448B 95.84B 650B 254B 3,149B 251B 245B 10,941B
Net income 12.43B 10.93B 10.15B 9.34B 17.51B 1,200B 17.84B 121B 47.28B 586B 46.66B 45.66B 2,037B 13.93B 12.24B 11.38B 10.46B 19.62B 1,345B 19.99B 136B 52.98B 657B 52.28B 51.16B 2,282B
Net Debt 19.2B 16.87B 15.68B 14.42B 27.03B 1,854B 27.55B 187B 73.01B 905B 72.05B 70.5B 3,145B 11.9B 10.46B 9.72B 8.94B 16.76B 1,149B 17.08B 116B 45.27B 561B 44.68B 43.72B 1,950B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-23 GBX 12,688.00 -0.11% 4,046,269
26-07-22 GBX 12,702.00 +1.68% 2,497,218
26-07-21 GBX 12,492.00 +0.90% 1,829,671
26-07-20 GBX 12,380.00 -1.70% 1,718,968
26-07-17 GBX 12,594.00 -0.27% 2,012,949
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
168.84USD
Average target price
212.16USD
Spread / Average Target
+25.65%

Quarterly revenue - Rate of surprise